Literature DB >> 20452774

cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance.

Guadalupe Sabio1, Roger J Davis.   

Abstract

The cJun NH(2)-terminal kinase isoform JNK1 is implicated in the mechanism of obesity-induced insulin resistance. Feeding a high-fat diet causes activation of the JNK1 signaling pathway, insulin resistance, and obesity in mice. Germ-line ablation of Jnk1 prevents both diet-induced obesity and insulin resistance. Genetic analysis indicates that the effects of JNK1 on insulin resistance can be separated from effects of JNK1 on obesity. Emerging research indicates that JNK1 plays multiple roles in the regulation of insulin resistance, including altered gene expression, hormone/cytokine production, and lipid metabolism. Together, these studies establish JNK1 as a potential pharmacological target for the development of drugs that might be useful for the treatment of insulin resistance, metabolic syndrome, and type 2 diabetes. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452774      PMCID: PMC2975251          DOI: 10.1016/j.tibs.2010.04.004

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  70 in total

1.  c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade.

Authors:  Yong Hee Lee; Jodel Giraud; Roger J Davis; Morris F White
Journal:  J Biol Chem       Date:  2002-11-01       Impact factor: 5.157

2.  SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2.

Authors:  Liangyou Rui; Minsheng Yuan; Daniel Frantz; Steven Shoelson; Morris F White
Journal:  J Biol Chem       Date:  2002-09-12       Impact factor: 5.157

3.  Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide.

Authors:  Hideaki Kaneto; Yoshihisa Nakatani; Takeshi Miyatsuka; Dan Kawamori; Taka-aki Matsuoka; Munehide Matsuhisa; Yoshitaka Kajimoto; Hidenori Ichijo; Yoshimitsu Yamasaki; Masatsugu Hori
Journal:  Nat Med       Date:  2004-09-26       Impact factor: 53.440

4.  Insulin signaling in health and disease.

Authors:  Morris F White
Journal:  Science       Date:  2003-12-05       Impact factor: 47.728

5.  An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue.

Authors:  Anja Jaeschke; Michael P Czech; Roger J Davis
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

6.  A central role for JNK in obesity and insulin resistance.

Authors:  Jiro Hirosumi; Gürol Tuncman; Lufen Chang; Cem Z Görgün; K Teoman Uysal; Kazuhisa Maeda; Michael Karin; Gökhan S Hotamisligil
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

7.  Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice.

Authors:  Peter J Klover; Teresa A Zimmers; Leonidas G Koniaris; Robert A Mooney
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

8.  Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

Authors:  Joseph J Senn; Peter J Klover; Irena A Nowak; Teresa A Zimmers; Leonidas G Koniaris; Richard W Furlanetto; Robert A Mooney
Journal:  J Biol Chem       Date:  2003-01-30       Impact factor: 5.157

9.  Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo.

Authors:  Hyo-Jeong Kim; Takamasa Higashimori; So-Young Park; Hyejeong Choi; Jianying Dong; Yoon-Jung Kim; Hye-Lim Noh; You-Ree Cho; Gary Cline; Young-Bum Kim; Jason K Kim
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

Review 10.  JNK: a new therapeutic target for diabetes.

Authors:  Brydon L Bennett; Yoshitaka Satoh; Alan J Lewis
Journal:  Curr Opin Pharmacol       Date:  2003-08       Impact factor: 5.547

View more
  79 in total

1.  Two hydrophobic residues can determine the specificity of mitogen-activated protein kinase docking interactions.

Authors:  A Jane Bardwell; Lee Bardwell
Journal:  J Biol Chem       Date:  2015-09-14       Impact factor: 5.157

2.  Skeletal Muscle-Specific Deletion of MKP-1 Reveals a p38 MAPK/JNK/Akt Signaling Node That Regulates Obesity-Induced Insulin Resistance.

Authors:  Ahmed Lawan; Kisuk Min; Lei Zhang; Alberto Canfran-Duque; Michael J Jurczak; Joao Paulo G Camporez; Yaohui Nie; Timothy P Gavin; Gerald I Shulman; Carlos Fernandez-Hernando; Anton M Bennett
Journal:  Diabetes       Date:  2018-01-09       Impact factor: 9.461

Review 3.  NOD1: An Interface Between Innate Immunity and Insulin Resistance.

Authors:  Sydney L Rivers; Amira Klip; Adria Giacca
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

Review 4.  Promoting longevity by maintaining metabolic and proliferative homeostasis.

Authors:  Lifen Wang; Jason Karpac; Heinrich Jasper
Journal:  J Exp Biol       Date:  2014-01-01       Impact factor: 3.312

Review 5.  Skeletal muscle inflammation and insulin resistance in obesity.

Authors:  Huaizhu Wu; Christie M Ballantyne
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

6.  The MST3/STK24 kinase mediates impaired fasting blood glucose after a high-fat diet.

Authors:  Cristina Iglesias; Ebel Floridia; Miriam Sartages; Begoña Porteiro; María Fraile; Ana Guerrero; Diana Santos; Juan Cuñarro; Sulay Tovar; Rubén Nogueiras; Celia M Pombo; Juan Zalvide
Journal:  Diabetologia       Date:  2017-09-27       Impact factor: 10.122

7.  A critical role for PKR complexes with TRBP in Immunometabolic regulation and eIF2α phosphorylation in obesity.

Authors:  Takahisa Nakamura; Ryan C Kunz; Cai Zhang; Taishi Kimura; Celvie L Yuan; Brenna Baccaro; Yuka Namiki; Steven P Gygi; Gökhan S Hotamisligil
Journal:  Cell Rep       Date:  2015-04-02       Impact factor: 9.423

Review 8.  Chromatin-tethered MAPKs.

Authors:  Aileen M Klein; Elma Zaganjor; Melanie H Cobb
Journal:  Curr Opin Cell Biol       Date:  2013-02-20       Impact factor: 8.382

Review 9.  Cell Signaling and Stress Responses.

Authors:  Gökhan S Hotamisligil; Roger J Davis
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

10.  Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese mice.

Authors:  Hongfeng Jiang; Marit Westerterp; Chunjiong Wang; Yi Zhu; Ding Ai
Journal:  Diabetologia       Date:  2014-08-14       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.